Table 1.
Clinical characteristics of the study population.
| Characteristics | Control(n = 63) | CAD(n = 76) | p-value |
|---|---|---|---|
| Sex [male (%)] | 38 (60.3) | 55 (72.4) | 0.150 |
| Age (years) | 63.83 ± 1.28 | 66.47 ± 1.28 | 0.148 |
| BMI (kg/m2) | 23.01 ± 0.30 | 25.12 ± 0.32 | <0.001 |
| Smoking (%) | 8 (12.7) | 12 (15.8) | 0.637 |
| SBP (mm Hg) | 127.02 ± 2.41 | 135.12 ± 2.20 | <0.05 |
| DBP (mm Hg) | 74.70 ± 1.29 | 75.82 ± 1.20 | 0.527 |
| TC (mmol/L) | 4.29 ± 0.15 | 4.26 ± 0.14 | 0.900 |
| TG (mmol/L) | 1.37 ± 0.91 | 2.26 ± 0.40 | <0.05 |
| LDL-C (mmol/L) | 2.66 ± 0.12 | 2.95 ± 0.13 | 0.107 |
| HDL-C (mmol/L) | 1.17 ± 0.36 | 1.04 ± 0.34 | <0.01 |
| FBG (mmol/L) | 5.70 ± 0.19 | 7.16 ± 0.40 | <0.01 |
| TNF-α (pg/mL) | 33.80 ± 1.43 | 38.16 ± 1.52 | <0.05 |
| IL-6 (pg/mL) | 22.56 ± 0.53 | 25.29 ± 0.80 | <0.01 |
| IL-8 (pg/mL) | 20.31 ± 0.89 | 25.58 ± 2.01 | <0.05 |
| CTRP1 (ng/mL) | 9.31 ± 0.56 | 17.24 ± 1.07 | <0.001 |
Data are presented as mean ± SE. CAD, coronary heart disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; FBG, fasting blood glucose; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; IL-8, interleukin-8; CTRP1, C1q/TNF-related protein-1.